Pharmaceutical

EHA 2024: Monoclonal antibodies continue to dominate mu...

Trial investigators anticipate that the FDA will decide on approval for linvosel...

Sarepta’s Elevidys secures US label expansion for DMD

Sarepta’s stock rose by over 36% following the positive news of the FDA expandin...

Tectonic bets on GPCR heart failure drug following reve...

The company has also raised $130.7m in a private placement, which along with Tec...

WHO warns of “harmful” fake Ozempic in circulation in A...

Both Novo Nordisk and Eli Lilly have filed lawsuits against unapproved sellers o...

South Korea seeks to accelerate drug reimbursement admi...

South Korea is moving forward with reforming its national health insurance syste...

Emergent to sell US sterile manufacturing facility to Bora

Emergent BioSolutions has agreed to divest its sterile manufacturing facility in...

Johnson & Johnson seeks FDA approval for Tremfya for Cr...

Johnson & Johnson (J&J) has submitted an sBLA seeking approval from the US FDA f...

TYRA-200 by Tyra Biosciences for Bile Duct Cancer (Chol...

TYRA-200 is under clinical development by Tyra Biosciences and currently in Phas...

SGNB-7H4V by Pfizer for Peritoneal Cancer: Likelihood o...

SGNB-7H4V is under clinical development by Pfizer and currently in Phase I for P...

SGNB-7H4V by Pfizer for Bile Duct Cancer (Cholangiocarc...

SGNB-7H4V is under clinical development by Pfizer and currently in Phase I for B...

SGNB-7H4V by Pfizer for Epithelial Ovarian Cancer: Like...

SGNB-7H4V is under clinical development by Pfizer and currently in Phase I for E...

IMA-203CD8 by Immatics for Bile Duct Cancer (Cholangioc...

IMA-203CD8 is under clinical development by Immatics and currently in Phase II f...

SGNB-7H4V by Pfizer for Human Epidermal Growth Factor R...

SGNB-7H4V is under clinical development by Pfizer and currently in Phase I for H...

IBI-343 by Innovent Biologics for Solid Tumor: Likeliho...

IBI-343 is under clinical development by Innovent Biologics and currently in Pha...

ILution travoprost by Glaukos for Ocular Hypertension: ...

ILution travoprost is under clinical development by Glaukos and currently in Pha...

Anti-RANKL Monoclonal Antibody by Jiangsu Pacific Meinu...

Anti-RANKL Monoclonal Antibody is under clinical development by Jiangsu Pacific ...